Mei Pharma, INC Schedule 13G passive stakes

Alexander Schornstein has divested all shares in Lite Strategy, Inc., reporting 0% beneficial ownership as of June 30, 2026.

Alexander Schornstein has filed an amended Schedule 13G, reporting a 9.99% beneficial ownership stake in Lite Strategy, Inc.

The Vanguard Group has filed an amended Schedule 13G, reporting a 2% passive beneficial ownership stake in Lite Strategy Inc as of September 30, 2025.

Alexander Schornstein has increased his beneficial ownership in MEI Pharma, Inc. to 13.29% of common stock, coinciding with the company's rebranding to Lite Strategy, Inc.

Alexander Schornstein has reported a 6.53% beneficial ownership stake in MEI Pharma, Inc., totaling 2,115,000 shares of common stock.

Citadel entities, including Kenneth Griffin, have disclosed a combined beneficial ownership of 9.99% in MEI Pharma, Inc., totaling 3,245,888 shares.